[Non-drug-based management of Alzheimer's disease].

Soins Gerontol

groupe hospitalier Broca-Cochin-Hôtel Dieu, équipe d'accueil universitaire, Paris.

Published: September 2013

AI Article Synopsis

Article Abstract

Alzheimer's disease requires specific patient management. This can involve non-drug-based treatments such as a cognitive stimulation programme to reinforce the patient's skills. By offering a combination of information and training to the family and caregivers, the patient's quality of life can be improved.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[non-drug-based management
4
management alzheimer's
4
alzheimer's disease]
4
disease] alzheimer's
4
alzheimer's disease
4
disease requires
4
requires specific
4
specific patient
4
patient management
4
management involve
4

Similar Publications

Background: Austria is among the countries with the highest incidence and prevalence of osteoporotic fractures worldwide. Guidelines for the prevention and management of osteoporosis were first published in 2010 under the auspices of the then Federation of Austrian Social Security Institutions and updated in 2017. The present comprehensively updated guidelines of the Austrian Society for Bone and Mineral Research are aimed at physicians of all specialties as well as decision makers and institutions in the Austrian healthcare system.

View Article and Find Full Text PDF

Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab.

Pain Ther

October 2023

Migraine Specialist Brisbane, St Andrew's Place, Suite 312, Level 2, 33 North Street, Spring Hill, Brisbane, QLD, 4000, Australia.

Medication overuse headache (MOH) places both a physical and emotional burden on patients. MOH may occur as a consequence of a negative spiral of events comprising an increasing number of headache days while taking frequent or excessive amounts of medications for acute treatment of headaches or migraine. Despite acute and prophylactic treatment options, there remains a complex subset of patients who fail first-line oral prophylactic therapies due to insufficient response or failure to tolerate, and require access to new prophylactic treatment options, including calcitonin gene-related peptide (CGRP) inhibitors such as eptinezumab.

View Article and Find Full Text PDF

[Expert consensus on late stage of critical care management].

Zhonghua Nei Ke Za Zhi

May 2023

Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

We wished to establish an expert consensus on late stage of critical care (CC) management. The panel comprised 13 experts in CC medicine. Each statement was assessed based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) principle.

View Article and Find Full Text PDF

Background: Long-term prescriptions of strong opioids for chronic noncancer pain-which are not supported by scientific evidence-suggest miscalibrated risk perceptions among those who prescribe, dispense, and take opioids. Because risk perceptions and behaviors can differ depending on whether people learn about risks through description or experience, we investigated the effects of descriptive versus simulated-experience educative formats on physicians' risk perceptions of strong opioids and their prescription behavior for managing chronic noncancer pain.

Methods: Three hundred general practitioners and 300 pain specialists in Germany-enrolled separately in two independent exploratory randomized controlled online trials-were randomly assigned to either a descriptive format (fact box) or a simulated-experience format (interactive simulation).

View Article and Find Full Text PDF

Background: Opioid prescribing to treat chronic non-cancer pain has rapidly increased, despite a lack of evidence for long-term safety and effectiveness. A pain review service was developed to work with patients taking opioids long-term to explore opioid use, encourage non-drug-based alternatives, and, where appropriate, support dose reduction.

Aim: To evaluate the service and its potential impact on opioid use, health and wellbeing outcomes, and quality of life (QoL).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!